Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase. [electronic resource]
Producer: 20021017Description: 280-7 p. digitalISSN:- 1352-0504
- 2-Aminopurine -- analogs & derivatives
- Adjuvants, Immunologic -- therapeutic use
- Adolescent
- Adult
- Antiviral Agents -- therapeutic use
- Cell Division
- Cells, Cultured
- Cytokines -- biosynthesis
- DNA, Viral -- blood
- Drug Therapy, Combination
- Famciclovir
- Female
- Hepatitis B Core Antigens -- immunology
- Hepatitis B Surface Antigens -- immunology
- Hepatitis B e Antigens -- blood
- Hepatitis B virus -- genetics
- Hepatitis B, Chronic -- blood
- Humans
- Immune Tolerance
- Male
- Middle Aged
- T-Lymphocytes -- drug effects
- Thymalfasin
- Thymosin -- analogs & derivatives
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.